Your browser doesn't support javascript.
loading
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.
Kim, Seok Jin; Jo, Jae-Cheol; Yoon, Dok Hyun; Yang, Deok-Hwan; Yoon, Sang Eun; Lee, Gyeong-Won; Kong, Jee Hyun; Park, Yong; Kang, Ka-Won; Lee, Ho-Sup; Oh, Sung Yong; Shin, Ho-Jin; Lee, Won Sik; Choi, Yoon Seok; Jeong, Seong Hyun; Kim, Min Kyoung; Kang, Hye Jin; Yi, Jun Ho; Lim, Sung-Nam; Yhim, Ho-Young; Do, Young Rok; Yun, Hwan Jung; Eom, Hyeon-Seok; Lee, Mark Hong; Suh, Cheolwon; Kim, Won Seog.
Afiliación
  • Kim SJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Jo JC; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Yoon DH; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.
  • Yang DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Yoon SE; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Lee GW; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kong JH; Division of Hematology and Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Changwon, Republic of Korea.
  • Park Y; Department of Hematology-oncology, Division of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Kang KW; Cancer of Evidence Based Medicine, Institute of Convergence Science, Yonsei University, Seoul, Republic of Korea.
  • Lee HS; Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Oh SY; Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Shin HJ; Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Lee WS; Department of Internal Medicine, Dong-A University Medical Center, Busan, Republic of Korea.
  • Choi YS; Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea.
  • Jeong SH; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Republic of Korea.
  • Kim MK; Division of Hematology-Oncology, Department of Internal Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kang HJ; Division of Hematology-Oncology, Department of Internal Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Yi JH; Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.
  • Lim SN; Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Yhim HY; Department Internal Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.
  • Do YR; Department of Internal Medicine, Haeundae Baek Hospital, Busan, Republic of Korea.
  • Yun HJ; Department of Internal Medicine, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.
  • Eom HS; Department of Internal Medicine, Dongsan Medical Center, Daegu, Republic of Korea.
  • Lee MH; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Suh C; Hematology-Oncology Clinic, National Cancer Center, Go-Yang, Republic of Korea.
  • Kim WS; Division of Hematology-Oncology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Republic of Korea.
Front Oncol ; 13: 1230629, 2023.
Article en En | MEDLINE | ID: mdl-37675232

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Clinical_trials Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article